Determinants of adverse outcomes following patent foramen ovale closure in elderly patients
EuroIntervention · 2024
DOI: 10.4244/eij-d-24-00156 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift EuroIntervention, 2024. Verfasst von Julio I Farjat-Pasos und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Quebec Heart and Lung Institute, Québec, QC, Canada. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Cardiac Catheterization, Atrial Fibrillation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Limited data are available on transcatheter patent foramen ovale (PFO) closure outcomes in the elderly. AIMS: Through this study, we aimed to determine the incidence and predictors of adverse events (recurrent cerebrovascular events [CVE] and atrial fibrillation [AF]) post-PFO closure in older patients with cryptogenic events. METHODS: This multicentre international study included patients over 60 years undergoing PFO closure for cryptogenic thromboembolic events. A dedicated database compiled baseline, procedural, and follow-up data. Competing risk and adjusted outcome predictor analyses were conducted. RESULTS: A total of 689 patients were included (median age 65 years, 41.2% female, mean Risk of Paradoxical Embolism [RoPE] score 4.5). The procedural success rate was 99.4%. After a median follow-up of 2 (interquartile range 1-5) years, 66 patients (9.6%) had died. CVE and stroke rates were 1.21 and 0.55 per 100 patient-years, respectively. Diabetes (hazard ratio [HR] 3.89, 95% confidence interval [CI]: 1.67-9.07; p=0.002) and atrial septal aneurysm (ASA; HR 5.25, 95% CI: 1.56-17.62; p=0.007) increased the CVE risk. New-onset AF occurred at a rate of 3.30 per 100 patient-years, with 51.3% within one month post-procedure. Older age (HR 1.05 per year, 95% CI: 1.00-1.09; p=0.023) and the absence of hypertension (HR 2.04, 95% CI: 1.19-3.57; p=0.010) were associated with an increased risk of AF. CONCLUSIONS: Older patients undergoing PFO closure had a relatively low rate of CVE and new-onset AF after a median follow-up of 2 years. The presence of diabetes, ASA, and a more advanced age determined an increased risk of adverse clinical events. These factors may be considered in the clinical decision-making process regarding PFO closure in this challenging population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiology Department, Quebec Heart and Lung Institute, Québec, QC, Canada.
- Pediatric Cardiology Department, Centre Hospitalier Universitaire de Québec, Québec, QC, Canada.
- Sorbonne Université, ACTION Study Group, INSERM UMRS_1166, Institut de Cardiologie (AP-HP), Paris, France.
- Cardiology Department, Toronto General Hospital, Toronto, ON, Canada.
- Cardiology Department, Bichat-Claude-Bernard Hospital, Paris, France.
- Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Zitieren
APA
Farjat-Pasos, J. I., Guedeney, P., Horlick, E., Abtan, J., Nombela-Franco, L., Hibbert, B., Sondergaard, L., Freixa, X., Masson, J. B., Cruz-González, I., Estévez-Loureiro, R., Faroux, L., Shah, A. H., Abrahamyan, L., Mesnier, J., Jerónimo, A., Abdel-Razek, O., Jørgensen, T. H., Asmar, M. A., …, & Rodés-Cabau, J. (2024). Determinants of adverse outcomes following patent foramen ovale closure in elderly patients. EuroIntervention. https://doi.org/10.4244/eij-d-24-00156
Vancouver
Farjat-Pasos JI, Guedeney P, Horlick E, Abtan J, Nombela-Franco L, Hibbert B, et al. Determinants of adverse outcomes following patent foramen ovale closure in elderly patients. EuroIntervention. 2024. doi:10.4244/eij-d-24-00156
BibTeX
@article{FarjatPasos2024,
author = {Farjat-Pasos, Julio I and Guedeney, Paul and Horlick, Eric and Abtan, Jeremie and Nombela-Franco, Luis and Hibbert, Benjamin and Sondergaard, Lars and Freixa, Xavier and Masson, Jean-Bernard and Cruz-González, Ignacio and Estévez-Loureiro, Rodrigo and Faroux, Laurent and Shah, Ashish H and Abrahamyan, Lusine and Mesnier, Jules and Jerónimo, Adrián and Abdel-Razek, Omar and Jørgensen, Troels Højsgaard and Asmar, Mike Al and Sitbon, Samuel and Abalhassan, Mohammed and Robichaud, Mathieu and Houde, Christine and Côté, Mélanie and Chamorro, Angel and Lanthier, Sylvain and Verreault, Steve and Montalescot, Gilles and Rodés-Cabau, Josep},
title = {Determinants of adverse outcomes following patent foramen ovale closure in elderly patients},
journal = {EuroIntervention},
year = {2024},
doi = {10.4244/eij-d-24-00156}
}
EUVIMED